Navigation Links
Lexicon to Report Fourth Quarter and Year End 2012 Financial Results on February 21, 2013
Date:2/18/2013

THE WOODLANDS, Texas, Feb. 18, 2013 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, will release its fourth quarter and year end 2012 financial results on Thursday, February 21, 2013 before the financial markets open.  Lexicon management will hold a conference call and webcast to discuss clinical development progress and financial results for fourth quarter and year end 2012 at 11:00 a.m. Eastern Time on February 21, 2013. 

The dial-in number for the conference call is 888-645-5875 (within the US/Canada) or 970-300-1531 (international).  The conference ID for all callers is 12316846.  Investors can access a live webcast of the call at www.lexpharma.com.  An archived version of the webcast will be available on the website through March 21, 2013.

About Lexicon
Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has multiple drug programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement
This press release contains "forward-looking" statements, including statements relating to Lexic
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lexicon Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
2. FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid Syndrome
3. Research and Markets: Cell Therapy - Technologies, Markets and Companies - 2013 Report
4. BioInformatics LLC New Market Report – Best Practices Guide for Advertising to Life Scientists
5. Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
6. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on February 14, 2013
7. Neuland Labs Reports Third Quarter Fiscal Year 2013 Financial Results
8. Intraocular Lens (IOL) Market Worth $3.8 Billion By 2018 Say New Research Report at ReportsnReports.com
9. Regenerative Medicine and Stem Cells Market Deals Analysis in New Research Report at ReportsnReports.com
10. The MedZilla.com Employment Report for February, 2013: Health Care Sector Stimulates Job Growth Throughout the Recession
11. Cellular Therapy Market and Cord Blood Market 2013 Industry Research Report: MarketResearchReports.Biz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... at Indiana University Bloomington have described the self-assembly ... development with potential value for the field of ... photovoltaic cells. , Their paper, "Anion-Induced Dimerization of ... 2D Self-Assembled Crystals," has been published online by ... Royal Society of Chemistry. It is the first ...
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® ... bearings are uniquely suited to prevent loss of lubrication ... the high temperatures . , Recently, a manufacturer ... engineers at Graphite Metallizing to overcome problems with movement ... operation, pans containing blocks of powder mixture are loaded ...
(Date:7/31/2014)... Francisco, California (PRWEB) July 31, 2014 ... systems that inform therapeutic decision-making in oncology, today announced ... August 14, 2014 to discuss the Company's financial results ... provide an update about the business in the current ... audio call beginning on Thursday, August 14, 2014, at ...
(Date:7/31/2014)... Held at the Stanford Cancer Center, ... of the disease and its treatment. Survivors will find ... well as updates on the state-of-the-art with respect to ... for organizing this educational opportunity,” says KCA CEO Bill ... her colleagues have put together a program that balances ...
Breaking Biology Technology:Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2
... Dialysis Corporation,of America (Nasdaq: DCAI ) announced today ... on May 7, 2008, after the close of the,market. ... conjunction with,its first quarter 2008 earnings release the following ... interested in participating in the May 8, 2008 conference ...
... 25 Processes and products based on,biomass and ... industry in a wide range of applications such ... of industrial,biotechnology in Germany will be held at ... 27-30, 2008) in Chicago, Illinois.,The panel runs from ...
... Leader Discusses Pioneer Hi-Bred Biotechnology Leadership ... at Beijing ... ),partnerships with China,s public and private sectors will help increase,farm productivity ... William S. Niebur, vice president -- DuPont Crop,Genetics Research and Development, ...
Cached Biology Technology:Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date 2World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment 2DuPont Partnering with China to Increase Farm Productivity 2DuPont Partnering with China to Increase Farm Productivity 3
(Date:7/31/2014)... flowers- they are an iconic symbol of tropical ... the landscape. Some, like Hawaii,s State Flower- ... a relatively few botanists and Hawaiian conservation workers, ... intriguing related group of plants known as ... of Hibiscus species are in fact highly endangered. ...
(Date:7/31/2014)... Conn. , July 31, 2014 ... the growing m-commerce market, reminds investors and consumers ... smart wallet, Wocket™, that it will be on-air today, ... secure Wocket smart wallet will be featured in ... oriented television show that airs on the History ...
(Date:7/30/2014)... truffle uses reversible epigenetic processes to regulate its genes, ... - a picture of the genome regulation taking place ... journal Genome Biology and illustrates how the ... ,jumping genes,. The authors say this may shed light ... , Black truffles (Tuber melanosporum), also known as Prigord ...
Breaking Biology News(10 mins):Brother of Hibiscus is found alive and well on Maui 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 3How black truffles deal with the jumpers in their genome 2
... synthetic life forms are at risk of being unduly ... are brought into the 21st century, an expert from The ... ANU College of Law takes a broad look at the ... biological inventions in his new book and the prognosis ...
... N.C. A small group of patients with a ... with an injectable microfoam experienced no neurological, visual or ... to preliminary results from a phase II trial. The ... D.C., at the annual scientific meeting of the Society ...
... CITY Two major eye diseases and leading causes of ... even prevented by drugs that activate a protein found ... Utah School of Medicine and several other institutions have ... diseases was prevented and even reversed when the protein, ...
Cached Biology News:Biotechnology needs 21st century patent system: Expert 2Improved foam for varicose veins found to be safe in preliminary results from phase II trial 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 3
Hepatocyte Differentiation Environment...
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
...
Coating : Poly-D-Lysine ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vol working : 2.5-3.0 ml ...
Biology Products: